Outcome Evaluation of Volume-Staged Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations.
Mantziaris G, Hajikarimloo B, Tos S, Pikis S, Chan J, Sneed P, McDermott M, Seymour Z, Grills I, Nabeel A, Reda W, Tawadros S, Abdelkarim K, El-Shehaby A, Emad R, Bin-Alamer O, Lunsford L, Niranjan A, Peker S, Samanci Y, Lee C, Yang H, Sheehan D, Sheehan K, Liscak R, Chytka T, Alzate J, Kondziolka D, Meng Y, Martinez Moreno N, Martinez Álvarez R, Hallan D, Fritch C, Jareczek F, Sciscent B, Mathieu D, Carrier L, Abdelsalam A, Starke R, Benjamin C, Almeida T, Pratap Singh S, Tripathi M, Speckter H, Lazo E, Chen C, Esquenazi Y, Becerril-Gaitan A, Amsbaugh M, Blanco A, Upadhyay R, Palmer J, Franzini A, Picozzi P, Lanterna L, Bowden G, Peterson J, Warnick R, Chiang V, Ishaque M, Protopapa M, Sheehan J. Outcome Evaluation of Volume-Staged Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations. Neurosurgery 2025 PMID: 40788018, DOI: 10.1227/neu.0000000000003682.Peer-Reviewed Original ResearchSingle-session stereotactic radiosurgeryArteriovenous malformationsVS-SRSPrescription doseObliteration rateFavorable outcomeStereotactic radiosurgeryAdverse radiation effect ratesVolume-staged stereotactic radiosurgeryMedian prescription doseAdverse radiation effectsMulticenter retrospective cohortArteriovenous malformation nidusClinical follow-upCerebral arteriovenous malformationsReduced treatment volumesNidus volumeMedian agePatient yearsDiffuse nidusRetrospective cohortRepeated TreatmentFollow-upTreatment volumeTreatment planning
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply